Article
A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.
Clinical pharmacology and therapeutics - 1 Apr 2003
Sofowora G G, Dishy V, Muszkat M, Xie H G, Kim R B, Harris P A, Prasad H C, Byrne D W, Nair U B, Wood A J J, Stein C M
Abstract excerpt
BACKGROUND: A common polymorphism of the beta(1)-adrenergic receptor Arg389Gly markedly affects function in vitro, but little is known about its in vivo significance. METHODS AND RESULTS: Resting and exercise hemodynamic responses were measured in subjects homozygous for Arg389 (n = 21) or Gly389 (n = 13) alleles before and 3 hours after administration of a beta-blocker, atenolol. Demographic characteristics and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
